We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Hematology Point-of-Care System Has Reread Functionality

By LabMedica International staff writers
Posted on 10 Mar 2009
A point-of-care hematology system, which combines centrifugation and analysis, now comes with reread functionality.

The QBC Star point-of-care hematology system is the simplest solution for patient bedside testing. More...
The system utilizes Buffy coat analysis technology using Acridine orange as a fluorescent medium, and the dry reagents contained in the QBC Star tube facilitate testing and analysis without the liquid reagents and liquid waste of impedance. Combining centrifugation and analysis in one machine, the QBC Star offers a fully automated complete blood count (CBC) analysis in one simple step.

An upgrade allows the user to reread a sample that has already been spun and to assess precision as well as accuracy, as testing of the same tube can be repeated for confirmation of the results. Troubleshooting is also made easier as a tube can be removed from the Star, assessed and then placed in the analyzer again for a second run. All new QBC Star systems have this functionality, and older systems can acquire it via a simple software upgrade. The user therefore can reread a sample that has already been spun and assess precision as well as accuracy, as testing of the same tube can be repeated for confirmation of the results.

The QBC Star and QBC Autoread measure the clinically significant parameters most requested by physicians, and features of the QBC range include true Point Of Care, leading edge technology, venous or capillary sample, no liquid waste or reagents and no user maintenance.

QBC Europe (Horich, Bolton, UK) is a division of Woodley Equipment Company Ltd. It is the master distributor in Europe, Africa, and the Middle East for QBC Diagnostics Inc.

Related Links:

QBC Europe




Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
New
Gold Member
Pre- Eclampsia Control
Acusera Pre-Eclampsia Control
Food Allergy Screening ELISA Kit
Allerquant 14G B ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: New findings demonstrate that anti-Müllerian hormone (AMH) may help identify which breast cancer patients are most likely to benefit from chemotherapy plus endocrine therapy (Image Credit: Shutterstock)

AMH Test Helps Predict Adjuvant Chemotherapy Benefit in Premenopausal Breast Cancer

Hormone receptor-positive, human epidermal growth factor receptor 2-negative (HR+/HER2-) breast cancer can present a difficult treatment decision in premenopausal patients with low recurrence scores.... Read more

Molecular Diagnostics

view channel
Image Credit: iStock

Sequencing-Based Newborn Screening Identifies Pediatric Cancer Risk at Birth

Newborn screening in the United States relies on heel-stick blood spots to identify rare, treatable disorders through biochemical testing, but these programs generally do not assess inherited cancer risk... Read more

Microbiology

view channel
Image: The QIAstat-Dx BCID GPF Plus AMR Panel is the first QIAstat-Dx panel for bloodstream infections to receive FDA clearance (Photo courtesy of Qiagen)

FDA Clears One-Hour Panel for Bloodstream Infection and AMR Detection

Bloodstream infections can rapidly progress to sepsis, a life-threatening condition affecting an estimated 1.7 million adults in the U.S. each year. Rapid identification of pathogens and antimicrobial... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.